Found: 15
Select item for more details and to access through your institution.
Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-00831-4
- By:
- Publication type:
- Article
Long-Term Carbapenems Antimicrobial Stewardship Program.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 1, p. 15, doi. 10.3390/antibiotics10010015
- By:
- Publication type:
- Article
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor‐induced liver injury.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 7, p. 865, doi. 10.1111/apt.17898
- By:
- Publication type:
- Article
RESEARCH ARTICLE Open Access Epidemiology and impact of a multifaceted approach in controlling central venous catheter associated blood stream infections outside the intensive care unit.
- Published in:
- BMC Infectious Diseases, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2334-13-445
- By:
- Publication type:
- Article
Epidemiology and impact of a multifaceted approach in controlling central venous catheter associated blood stream infections outside the intensive care unit.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Current State-of-the-Art Therapy for Malignant Pleural Mesothelioma and Future Options Centered on Immunotherapy.
- Published in:
- Cancers, 2023, v. 15, n. 24, p. 5787, doi. 10.3390/cancers15245787
- By:
- Publication type:
- Article
Expression of TILs and Patterns of Gene Expression from Paired Samples of Malignant Pleural Mesothelioma (MPM) Patients.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3611, doi. 10.3390/cancers15143611
- By:
- Publication type:
- Article
Interrelations between Patients' Clinicopathological Characteristics and Their Association with Response to Immunotherapy in a Real-World Cohort of NSCLC Patients.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3249, doi. 10.3390/cancers13133249
- By:
- Publication type:
- Article
Dynamic changes in circulating tumor DNA assessed by shallow whole‐genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 5, p. 779, doi. 10.1002/1878-0261.13409
- By:
- Publication type:
- Article
Molecular profiling of long‐term responders to immune checkpoint inhibitors in advanced non‐small cell lung cancer.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 4, p. 887, doi. 10.1002/1878-0261.12891
- By:
- Publication type:
- Article
A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non‐small cell lung cancer.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 14, p. 2790, doi. 10.1002/cam4.4635
- By:
- Publication type:
- Article
Herpes simplex encephalitis in the context of immune checkpoint inhibitors: a complex interplay.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Genetic evolution to tyrosine kinase inhibitory therapy in patients with EGFR-mutated non-small-cell lung cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Hepatic Rupture as the Initial Presentation of an EGFR -Mutated Lung Adenocarcinoma: A Case Report.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.837630
- By:
- Publication type:
- Article
Evidence-based pharmacological prophylaxis recommendations for venous thromboembolism in hospitalized acutely ill medical patients: a systematic review of clinical practice guidelines.
- Published in:
- Jornal Vascular Brasileiro, 2023, v. 22, p. 1, doi. 10.1590/1677-5449.202300672
- By:
- Publication type:
- Article